• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

汉黄芩素抑制基质金属蛋白酶-9 的活性并抑制人肝癌细胞的迁移和侵袭。

Wogonin Suppresses the Activity of Matrix Metalloproteinase-9 and Inhibits Migration and Invasion in Human Hepatocellular Carcinoma.

机构信息

Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, 12 Jichang Road, Guangzhou 510405, China.

College of mechanical engineering, Yangzhou University, 88 South University Ave., Yangzhou 225009, China.

出版信息

Molecules. 2018 Feb 11;23(2):384. doi: 10.3390/molecules23020384.

DOI:10.3390/molecules23020384
PMID:29439451
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6017513/
Abstract

As one of the major active ingredients in Radix Scutellariae, wogonin has been shown to be associated with various pharmacological activities on cancer cell growth, apoptosis, and cell invasion and migration. Here, we demonstrated that wogonin may harbor potential anti-metastatic activities in hepatocarcinoma (HCC). The anti-metastasis potential of wogonin and its underlying mechanisms were evaluated by ligand-protein docking approach, surface plasmon resonance assay, and in vitro gelatin zymography studies. Our results showed that wogonin (100 μM, 50 μM) suppressed MHCC97L and PLC/PRF/5 cells migration and invasion in vitro. The docking approach and surface plasmon resonance assay indicated that the potential binding affinity between wogonin and matrix metalloproteinase-9 (MMP-9) may lead to inhibition of MMP-9 activity and further leads to suppression of tumor metastasis. This conclusion was further verified by Western blot results and gelatin zymography analysis. Wogonin might be a potent treatment option for disrupting the tumor metastasis that favors HCC development. The potential active targets from computational screening integrated with biomedical study may help us to explore the molecular mechanism of herbal medicines.

摘要

作为黄芩的主要活性成分之一,汉黄芩素已被证明与癌细胞生长、凋亡以及细胞侵袭和迁移的各种药理活性有关。在这里,我们证明汉黄芩素可能在肝癌(HCC)中具有潜在的抗转移活性。通过配体-蛋白对接方法、表面等离子体共振分析和体外明胶酶谱分析评估了汉黄芩素的抗转移潜力及其潜在机制。我们的结果表明,汉黄芩素(100 μM、50 μM)抑制 MHCC97L 和 PLC/PRF/5 细胞的体外迁移和侵袭。对接方法和表面等离子体共振分析表明,汉黄芩素与基质金属蛋白酶-9(MMP-9)之间的潜在结合亲和力可能导致 MMP-9 活性的抑制,进而抑制肿瘤转移。Western blot 结果和明胶酶谱分析进一步验证了这一结论。汉黄芩素可能是一种有效的治疗选择,可以破坏有利于 HCC 发展的肿瘤转移。计算筛选与生物医学研究相结合的潜在活性靶点可能有助于我们探索草药的分子机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3834/6017513/a9db1b0ff3f5/molecules-23-00384-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3834/6017513/862491c9605e/molecules-23-00384-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3834/6017513/36f178d1580e/molecules-23-00384-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3834/6017513/a9db1b0ff3f5/molecules-23-00384-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3834/6017513/862491c9605e/molecules-23-00384-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3834/6017513/36f178d1580e/molecules-23-00384-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3834/6017513/a9db1b0ff3f5/molecules-23-00384-g003.jpg

相似文献

1
Wogonin Suppresses the Activity of Matrix Metalloproteinase-9 and Inhibits Migration and Invasion in Human Hepatocellular Carcinoma.汉黄芩素抑制基质金属蛋白酶-9 的活性并抑制人肝癌细胞的迁移和侵袭。
Molecules. 2018 Feb 11;23(2):384. doi: 10.3390/molecules23020384.
2
Wogonin, an active ingredient of Chinese herb medicine Scutellaria baicalensis, inhibits the mobility and invasion of human gallbladder carcinoma GBC-SD cells by inducing the expression of maspin.黄芩素,一种中草药黄芩的活性成分,通过诱导 maspin 的表达来抑制人胆囊癌细胞 GBC-SD 的迁移和侵袭。
J Ethnopharmacol. 2011 Oct 11;137(3):1373-80. doi: 10.1016/j.jep.2011.08.005. Epub 2011 Aug 6.
3
[Experimental study on inhibitory effect of wogonin on proliferation and invasion of breast cancer cells].汉黄芩素对乳腺癌细胞增殖和侵袭抑制作用的实验研究
Zhongguo Zhong Yao Za Zhi. 2014 Apr;39(8):1485-9.
4
Inhibitory effects of wogonin on the invasion of human breast carcinoma cells by downregulating the expression and activity of matrix metalloproteinase-9.研究发现,黄苓素通过下调基质金属蛋白酶-9 的表达和活性抑制人乳腺癌细胞的侵袭。
Toxicology. 2011 Apr 11;282(3):122-8. doi: 10.1016/j.tox.2011.01.018. Epub 2011 Feb 2.
5
Wogonin induces apoptosis in RPMI 8226, a human myeloma cell line, by downregulating phospho-Akt and overexpressing Bax.汉黄芩素通过下调磷酸化 Akt 和过表达 Bax 诱导 RPMI 8226(人骨髓瘤细胞系)细胞凋亡。
Life Sci. 2013 Jan 17;92(1):55-62. doi: 10.1016/j.lfs.2012.10.023. Epub 2012 Nov 8.
6
Wogonin suppresses stem cell-like traits of CD133 positive osteosarcoma cell via inhibiting matrix metallopeptidase-9 expression.汉黄芩素通过抑制基质金属蛋白酶-9的表达来抑制CD133阳性骨肉瘤细胞的干细胞样特性。
BMC Complement Altern Med. 2017 Jun 12;17(1):304. doi: 10.1186/s12906-017-1788-y.
7
Wogonin inhibits cell cycle progression by activating the glycogen synthase kinase-3 beta in hepatocellular carcinoma.汉黄芩素通过激活肝肿瘤细胞中的糖原合成酶激酶-3β来抑制细胞周期进程。
Phytomedicine. 2020 Mar;68:153174. doi: 10.1016/j.phymed.2020.153174. Epub 2020 Jan 18.
8
Oroxylin A inhibits matrix metalloproteinase-2/9 expression and activation by up-regulating tissue inhibitor of metalloproteinase-2 and suppressing the ERK1/2 signaling pathway.盐酸小檗碱通过上调基质金属蛋白酶抑制剂-2 并抑制 ERK1/2 信号通路来抑制基质金属蛋白酶-2/9 的表达和激活。
Toxicol Lett. 2012 Mar 25;209(3):211-20. doi: 10.1016/j.toxlet.2011.12.022. Epub 2012 Jan 10.
9
Anti-tumor activity of wogonin, an extract from Scutellaria baicalensis, through regulating different signaling pathways.黄芩提取物汉黄芩素通过调节不同信号通路发挥抗肿瘤活性。
Chin J Nat Med. 2017 Jan;15(1):15-40. doi: 10.1016/S1875-5364(17)30005-5.
10
Wogonin suppresses melanoma cell B16-F10 invasion and migration by inhibiting Ras-medicated pathways.汉黄芩素通过抑制Ras介导的信号通路抑制黑色素瘤细胞B16-F10的侵袭和迁移。
PLoS One. 2014 Sep 9;9(9):e106458. doi: 10.1371/journal.pone.0106458. eCollection 2014.

引用本文的文献

1
Wogonin inhibits radiation-induced DNA damage repair in hepatocellular carcinoma cells by upregulating p21.汉黄芩素通过上调p21抑制肝癌细胞中辐射诱导的DNA损伤修复。
Korean J Physiol Pharmacol. 2025 Jul 1;29(4):419-429. doi: 10.4196/kjpp.24.213. Epub 2025 Feb 6.
2
Knockdown and Overexpression Experiments to Investigate the Inhibitory Mechanism of Fuzheng Xiaozheng Prescription, an Effective Chinese Herbal Formula for the Clinical Treatment of Hepatocellular Carcinoma.敲低和过表达实验以探究扶正消症方(一种用于临床治疗肝细胞癌的有效中药方剂)的抑制机制
Pharmaceuticals (Basel). 2024 Aug 31;17(9):1159. doi: 10.3390/ph17091159.
3

本文引用的文献

1
Associations between prescribed Chinese herbal medicine and risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide population-based cohort study.慢性乙型肝炎患者中开具的中草药与肝细胞癌风险之间的关联:一项基于全国人群的队列研究。
BMJ Open. 2017 Jan 25;7(1):e014571. doi: 10.1136/bmjopen-2016-014571.
2
Curcumin suppresses colon cancer cell invasion via AMPK-induced inhibition of NF-κB, uPA activator and MMP9.姜黄素通过AMPK诱导抑制NF-κB、尿激酶型纤溶酶原激活剂和基质金属蛋白酶9来抑制结肠癌细胞的侵袭。
Oncol Lett. 2016 Nov;12(5):4139-4146. doi: 10.3892/ol.2016.5148. Epub 2016 Sep 16.
3
Development of sorafenib-related side effects in patients diagnosed with advanced hepatocellular carcinoma treated with sorafenib: a systematic-review and meta-analysis of the impact on survival.
Wogonin attenuates vascular remodeling by inhibiting smooth muscle cell proliferation and migration in hypertensive rat.
汉黄芩素通过抑制高血压大鼠平滑肌细胞的增殖和迁移来减轻血管重塑。
Korean J Physiol Pharmacol. 2024 Jan 1;28(1):39-48. doi: 10.4196/kjpp.2024.28.1.39.
4
Wogonin, as a potent anticancer compound: From chemistry to cellular interactions.汉黄芩素,一种强效的抗癌化合物:从化学结构到细胞相互作用。
Exp Biol Med (Maywood). 2023 May;248(9):820-828. doi: 10.1177/15353702231179961. Epub 2023 Jun 30.
5
in the Treatment of Hepatocellular Carcinoma: Network Pharmacology Analysis and Experimental Validation.肝细胞癌治疗中的网络药理学分析与实验验证
Evid Based Complement Alternat Med. 2023 Feb 23;2023:4572660. doi: 10.1155/2023/4572660. eCollection 2023.
6
In Silico and In Vitro Studies on the Mechanisms of Chinese Medicine Formula (Yiqi Jianpi Jiedu Formula) in the Treatment of Hepatocellular Carcinoma.中药方剂(益气健脾解毒方)治疗肝癌的体内外作用机制的研究
Comput Math Methods Med. 2022 Oct 29;2022:8669993. doi: 10.1155/2022/8669993. eCollection 2022.
7
The Therapeutic Potential of Wogonin Observed in Preclinical Studies.前临床研究中观察到的汉黄芩素的治疗潜力。
Evid Based Complement Alternat Med. 2021 Jun 15;2021:9935451. doi: 10.1155/2021/9935451. eCollection 2021.
8
Combination of Wogonin and Artesunate Exhibits Synergistic anti-Hepatocellular Carcinoma Effect by Increasing DNA-Damage-Inducible Alpha, Tumor Necrosis Factor α and Tumor Necrosis Factor Receptor-Associated Factor 3-mediated Apoptosis.汉黄芩素与青蒿琥酯联合使用通过增加DNA损伤诱导因子α、肿瘤坏死因子α和肿瘤坏死因子受体相关因子3介导的细胞凋亡发挥协同抗肝癌作用。
Front Pharmacol. 2021 May 5;12:657080. doi: 10.3389/fphar.2021.657080. eCollection 2021.
9
Network Pharmacology-Based Study on the Mechanism of for Hepatocellular Carcinoma Treatment.基于网络药理学的肝细胞癌治疗机制研究
Evid Based Complement Alternat Med. 2020 Oct 26;2020:8897918. doi: 10.1155/2020/8897918. eCollection 2020.
10
Flavonoids in Cancer Metastasis.癌症转移中的黄酮类化合物。
Cancers (Basel). 2020 Jun 8;12(6):1498. doi: 10.3390/cancers12061498.
索拉非尼治疗晚期肝细胞癌患者中索拉非尼相关副作用的发生情况:对生存影响的系统评价和荟萃分析
Expert Rev Gastroenterol Hepatol. 2017 Jan;11(1):75-83. doi: 10.1080/17474124.2017.1264874. Epub 2016 Nov 30.
4
Increased expression ratio of matrix metalloproteinase-9 (MMP9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) RNA levels in Iranian multiple sclerosis patients.伊朗多发性硬化症患者中基质金属蛋白酶-9(MMP9)与基质金属蛋白酶组织抑制剂(TIMP-1)RNA水平的表达比率增加。
Hum Antibodies. 2016;24(3-4):65-70. doi: 10.3233/HAB-160296.
5
Wogonin inhibits the proliferation and invasion, and induces the apoptosis of HepG2 and Bel7402 HCC cells through NF‑κB/Bcl-2, EGFR and EGFR downstream ERK/AKT signaling.汉黄芩素通过NF-κB/Bcl-2、表皮生长因子受体(EGFR)及EGFR下游的细胞外信号调节激酶/蛋白激酶B(ERK/AKT)信号通路抑制肝癌细胞系HepG2和Bel7402的增殖与侵袭,并诱导其凋亡。
Int J Mol Med. 2016 Oct;38(4):1250-6. doi: 10.3892/ijmm.2016.2700. Epub 2016 Aug 5.
6
Ligand and Structure-Based Approaches for the Identification of Peptide Deformylase Inhibitors as Antibacterial Drugs.基于配体和结构的方法用于鉴定肽脱甲酰基酶抑制剂作为抗菌药物
Int J Mol Sci. 2016 Jul 15;17(7):1141. doi: 10.3390/ijms17071141.
7
Cost-effectiveness of sorafenib versus SBRT for unresectable advanced hepatocellular carcinoma.索拉非尼与立体定向体部放疗治疗不可切除的晚期肝细胞癌的成本效益
Radiat Oncol. 2016 May 18;11:69. doi: 10.1186/s13014-016-0644-4.
8
Wogonoside prevents colitis-associated colorectal carcinogenesis and colon cancer progression in inflammation-related microenvironment via inhibiting NF-κB activation through PI3K/Akt pathway.汉黄芩苷通过PI3K/Akt途径抑制NF-κB激活,在炎症相关微环境中预防结肠炎相关的结直肠癌发生和结肠癌进展。
Oncotarget. 2016 Jun 7;7(23):34300-15. doi: 10.18632/oncotarget.8815.
9
Use of in-silico assays to characterize the ADMET profile and identify potential therapeutic targets of fusarochromanone, a novel anti-cancer agent.使用计算机模拟分析来表征新型抗癌剂夫沙罗色酮的ADMET特性并确定其潜在治疗靶点。
In Silico Pharmacol. 2015 Dec;3(1):6. doi: 10.1186/s40203-015-0010-5. Epub 2015 Jun 4.
10
Computational assay of Zanamivir binding affinity with original and mutant influenza neuraminidase 9 using molecular docking.使用分子对接技术对扎那米韦与原始型和突变型流感神经氨酸酶9的结合亲和力进行计算分析。
J Theor Biol. 2015 Nov 21;385:31-9. doi: 10.1016/j.jtbi.2015.08.019. Epub 2015 Sep 1.